Fresenius SE & Co.KGaA
Acronym: FSE
General Information
Identification Code: 047428334069-39
Website: [object Object]
Entity Form: SE & Co. KGaA
Registration Category: Companies & groups
Registration Date: 2/22/2019
Last Update: 2/29/2024
EP Accredited Number: 1
Mission & Interests
Goals: Fresenius SE & Co. KGaA (Frankfurt/Xetra: FRE) is a global healthcare company headquartered in Bad Homburg v. d. Höhe, Germany. In the 2023 fiscal year, Fresenius generated €22.3 billion in annual revenue with its more than 190,000 employees.
Fresenius offers solutions to the social challenges posed by a growing and ageing population and the resulting need for affordable, high-quality healthcare.
The Fresenius Group comprises the operating companies Fresenius Kabi and Fresenius Helios as well as the investment companies Fresenius Vamed and Fresenius Medical Care. With 140 hospitals and countless outpatient facilities, Fresenius Helios is the leading private hospital operator in Germany and Spain, treating around 26 million patients every year. Fresenius Kabi’s product portfolio includes a range of highly complex biopharmaceuticals, clinical nutrition, medical technology, and generic intravenous drugs.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Climate action
- Competition
- Consumers
- Customs
- Digital economy and society
- Economy, finance and the euro
- Employment and social affairs
- Environment
- Humanitarian aid and civil protection
- Justice and fundamental rights
- Public health
- Research and innovation
- Single market
- Taxation
- Trade
Levels of Interest:
- global
- sub-national
- european
- national
Activities
Main EU Legislative Proposals: Artificial Intelligence, Biosimilars, Chemical Regulations, Chemicals Strategy for Sustainability, Chronic Diseases, Circular Economy, Corporate Sustainability Due Dilligence, Environmental Policies, EU Green Deal, EU Trade Policy, European Cancer Plan, European Health Data Space, European Semester, Equal Pay Directive, Free Trade Agreements, Global Gateway Initiative, Global Health Policies, Health Technology Assessment, Horizon Europe Programme, Hospitals, Industrial Strategy, IP Legislation, Multiannual Financial Framework, Network and Information Security, Patients, Pricing and Reimbursement Policies, Public Health Policies, Raw Materials Act, REACH, Revision of Directive 2001/83/EC, Revision of Medical Device Regulation, Standardisation, Taxonomy, Waste Water, Zero Net Industry Act
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: Else-Kröner-Str. 1
Post Code: 61352
City: Bad Homburg
Country: GERMANY
Phone: [object Object]
EU Office
Address: 21, Rue Montoyer
Post Code: 1000
City: Brüssel
Country: BELGIUM
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: Please note that Fresenius Kabi Deutschland GmbH has its own entry in the Transparency Register (Identification number: 130305227617-65). All information given and registered values relate only to Fresenius SE & Co. KGaA.
Membership Information
Members10 Percent: 0
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 0
Members: 2
Members F T E: 1.25
Structure
Structure Type: Structure
Is Member Of: Fresenius Kabi AG, Helios Kliniken GmbH, Fresenius VAMED GMBH
https://www.fresenius.com/de/konzern-im-ueberblick
Organisation Members: Fresenius SE & Co.KGaA and its consolidated subsidiaries are represented in a large number of associations worldwide.
Memberships of Fresenius SE & Co.KGaA in organisations that would be relevant for the register are as follows:
- MedTech Europe
- Bundesverband der Arzneimittel-Hersteller e.V. (BAH)
- Bundesverband Medizintechnologie e. V. (BVmed)
- German Health Alliance (GHA)
- Deutsches Institut für Normung e. V. (DIN)
Relevant Memberships of Fresenius Kabi Deutschland GmbH can be found in the independet registry entry.